INZOLEN Injektions-/Infusionslösung
Recall
|
Medicines
|
18/08/2022
The marketing authorisation holder informed its customers on August 15, 2022 that increased cobalt concentrations were detected during the ongoing stability programme. For this reason, the batches mentioned are being recalled. The medicinal product is authorised in Germany and placed on the market in Austria under the Austrian Act on the Import of Medicinal Products.
| Name of the medicinal product | INZOLEN Injektions-/Infusionslösung |
|---|---|
| Marketing authorisation number(s) | Deutschland: 6072873.00.00 |
| Marketing authorisation holder | Dr. Franz Köhler Chemie GmbH |
| Batch number(s) | 2002151, 2002152, 2002716, 2002717, 2008451, 2008452, 2008551, 2008552, 2016151, 2016152, 2018851, 2018852, 2020916, 2020917, 2021051, 2021052, 2030116, 2030117, 2030851, 2030852, 2030951, 2030952, 2031551, 2031552 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-3972 |
Further inquiry note
Page last modified:
18/08/2022